Jubilant Pharma-Consolidation breakout can give good returns

Jubilant pharmova has been trading in a big range since last few years.
Stock has managed to close above the resistance and has also retested the breakout.
Stock has potential to fly from this levels.

Keep stock in watchlist. A nifty500 stock and hence can be relatively safer option.
Not a recommendation.
chartanalysisdarvasboxjubilantpharmanifty500PHARMARectanglestrongbreakoutSupply and Demandweeklybreakout

또한 다음에서도:

면책사항